
### [NCIT:C132814](http://purl.obolibrary.org/obo/NCIT_C132814)
**Label:** Pharyngeal Carcinoma by AJCC v8 Stage

**Subclasses:** [NCIT:C133003](http://purl.obolibrary.org/obo/NCIT_C133003) (Hypopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C133006](http://purl.obolibrary.org/obo/NCIT_C133006) (Stage II Hypopharyngeal Carcinoma AJCC v8), [NCIT:C132820](http://purl.obolibrary.org/obo/NCIT_C132820) (Stage IV Nasopharyngeal Carcinoma AJCC v8), [NCIT:C133007](http://purl.obolibrary.org/obo/NCIT_C133007) (Stage III Hypopharyngeal Carcinoma AJCC v8), [NCIT:C133005](http://purl.obolibrary.org/obo/NCIT_C133005) (Stage I Hypopharyngeal Carcinoma AJCC v8), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C6048](http://purl.obolibrary.org/obo/NCIT_C6048) (Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C6036](http://purl.obolibrary.org/obo/NCIT_C6036) (Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C9101](http://purl.obolibrary.org/obo/NCIT_C9101) (Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C9099](http://purl.obolibrary.org/obo/NCIT_C9099) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C132818](http://purl.obolibrary.org/obo/NCIT_C132818) (Stage II Nasopharyngeal Carcinoma AJCC v8), [NCIT:C132819](http://purl.obolibrary.org/obo/NCIT_C132819) (Stage III Nasopharyngeal Carcinoma AJCC v8), [NCIT:C133008](http://purl.obolibrary.org/obo/NCIT_C133008) (Stage IV Hypopharyngeal Carcinoma AJCC v8), [NCIT:C132816](http://purl.obolibrary.org/obo/NCIT_C132816) (Nasopharyngeal Carcinoma by AJCC v8 Stage), [NCIT:C132817](http://purl.obolibrary.org/obo/NCIT_C132817) (Stage I Nasopharyngeal Carcinoma AJCC v8), 

**Class expressions from DL-Learner:**

- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 38.93%


